Quoin Pharmaceuticals Ltd DRC (United States) is listed on the Nasdaq and has a market capitalization of $11.25 million, with shareholders equity totaling $3.93 million.
The company employs approximately 4 people and operates in the Other sector, within the Others industry.
Over the past 12 months, Quoin Pharmaceuticals Ltd DRC reported $- in revenue, generating net income of $-18.67 million.
Key financial metrics include a P/E ratio of -0.60, a price-to-book (P/B) ratio of 2.86, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker QNRX.